21
Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Embed Size (px)

Citation preview

Page 1: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Noninvasive assessment of left internal

mammary artery graft patency using

transthoracic color doppler

echocardiography before and after

Dipyridamole infusion

Noninvasive assessment of left internal

mammary artery graft patency using

transthoracic color doppler

echocardiography before and after

Dipyridamole infusion

Page 2: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

AimAim

Evaluation of the patency of LIMA on LAD by noninvasive transthoracic echocardiography

Evaluation of the patency of LIMA on LAD by noninvasive transthoracic echocardiography

Page 3: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Patients :Patients : 34 patients ( 27 males , 7 females ) Mean age : 61± 4 yrs CABG was done 4-11 yrs ago ( mean

7±2) All patients undergoing coronary

angiography because of recurrent anginal symptoms.

Doppler velocity profiles of LIMA were obtained in only 29 patients (because of techniqual problems).

34 patients ( 27 males , 7 females ) Mean age : 61± 4 yrs CABG was done 4-11 yrs ago ( mean

7±2) All patients undergoing coronary

angiography because of recurrent anginal symptoms.

Doppler velocity profiles of LIMA were obtained in only 29 patients (because of techniqual problems).

Page 4: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Methods:Methods:

Echocardiography was performed using vingmed CFM 800 ultrasound unit and a 5 MHZ mechanical sector transducer.

Echocardiography was performed using vingmed CFM 800 ultrasound unit and a 5 MHZ mechanical sector transducer.

Page 5: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

LIMA detectionLIMA detection Patients were examined in left lateral decobitus position .

Using modified left parasternal view.

Long axis images of LV were obtained .

Patients were examined in left lateral decobitus position .

Using modified left parasternal view.

Long axis images of LV were obtained .

Page 6: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Anterior of RVOT and anterior of interventricular sulcus was carefully examined by combined imaging and color flow mapping.

LIMA graft was identified as a tubular structure with color flow directed from base to apex.

Anterior of RVOT and anterior of interventricular sulcus was carefully examined by combined imaging and color flow mapping.

LIMA graft was identified as a tubular structure with color flow directed from base to apex.

Page 7: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

When the position of LIMA was identified, intraluminal flow signals were obtained using the pulsed doppler method

When the position of LIMA was identified, intraluminal flow signals were obtained using the pulsed doppler method

Page 8: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Six parameters were measured:

Six parameters weremeasured: Peak systolic velocity Peak diastolic velocity Mean systolic velocity Mean diastolic velocity Systolic velocity time integral Diastolic velocity time integral

Peak systolic velocity Peak diastolic velocity Mean systolic velocity Mean diastolic velocity Systolic velocity time integral Diastolic velocity time integral

Page 9: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Coronary angiography was done one day after echocardiography.

LIMA grafts were examined by using multiple projection and classified according to severity of LIMA Stenosis.

LAD after LIMA insertion was patent in all patients.

Coronary angiography was done one day after echocardiography.

LIMA grafts were examined by using multiple projection and classified according to severity of LIMA Stenosis.

LAD after LIMA insertion was patent in all patients.

Page 10: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Patient’s group according to angiographic findings:

Patient’s group according toangiographic findings:

Group 1 : LIMA was patent or had non significant stenosis.

Group 2 : LIMA had significant (>70%) stenosis .

Group 1 : LIMA was patent or had non significant stenosis.

Group 2 : LIMA had significant (>70%) stenosis .

Page 11: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

In all of patients, doppler velocity profile of LIMA was recorded before and after injection of dipyridamole.

In all of patients, doppler velocity profile of LIMA was recorded before and after injection of dipyridamole.

Page 12: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Angiographic resultsAngiographic results LIMA graft was patent in 12

patients. LIMA graft had nonsignificant

stenosis in 7 patients . LIMA graft had significant

stenosis in 10 patients .

LIMA graft was patent in 12 patients.

LIMA graft had nonsignificant stenosis in 7 patients .

LIMA graft had significant stenosis in 10 patients .

Page 13: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Echocardiographic resultsEchocardiographic results In all cases, there was

biphasic pattern of blood flow corresponding to systole and diastole.

Two different pattern were observed.

In all cases, there was biphasic pattern of blood flow corresponding to systole and diastole.

Two different pattern were observed.

Page 14: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

In group 1: In group 1:

Who had normal graft or moderate stenosis, flow was dominant during diastole. Dipyridamole induced an increase in diastolic flow in this group more than group 2 .

Who had normal graft or moderate stenosis, flow was dominant during diastole. Dipyridamole induced an increase in diastolic flow in this group more than group 2 .

Page 15: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Diastolic flow pattern of LIMA in group 1 Diastolic flow pattern of LIMA in group 1

Page 16: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

In group 2:In group 2:

Who had an occluded or severely stenosed LIMA graft. Flow was dominant during systole and low velocity profile were recorded during diastole.

Dipyridamole induced an increase in diastolic flow in this group lower than group 1 .

Who had an occluded or severely stenosed LIMA graft. Flow was dominant during systole and low velocity profile were recorded during diastole.

Dipyridamole induced an increase in diastolic flow in this group lower than group 1 .

Page 17: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Systolic flow pattern of LIMA in group 2Systolic flow pattern of LIMA in group 2

Page 18: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Advantages of this method:

Advantagesof this method:

Noninvasive Inexpensive Easy

Noninvasive Inexpensive Easy

Page 19: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Disadvantages of this method:

Disadvantagesof this method :

If significant stenosis of LAD after insertion of LIMA was present, LIMA flow pattern become similar to that LIMA stenosis.

In obese patients, LIMA flow pattern was not easily taken.

If significant stenosis of LAD after insertion of LIMA was present, LIMA flow pattern become similar to that LIMA stenosis.

In obese patients, LIMA flow pattern was not easily taken.

Page 20: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion

Result:Result: The echocardiographic

evaluation of LIMA is a simple , noninvasive method for the assessment of the graft patency.

Dipyridamole infusion also increase diastolic flow pattern in patent LIMA rather than stenosed LIMA.

The echocardiographic evaluation of LIMA is a simple , noninvasive method for the assessment of the graft patency.

Dipyridamole infusion also increase diastolic flow pattern in patent LIMA rather than stenosed LIMA.

Page 21: Noninvasive assessment of left internal mammary artery graft patency using transthoracic color doppler echocardiography before and after Dipyridamole infusion